[Skip to Navigation]
November 1973

Chemodectomas of the Middle Ear: A Comparison of Therapeutic Modalities

Author Affiliations

Charlottesville, Va
From the Department of Otolaryngology and Maxillofacial Surgery (Drs. Moore, Robbins, Fitz-Hugh) and the Division of Radiation Oncology, (Drs. Seale and Constable), University of Virginia Medical School, Charlottesville, Va.

Arch Otolaryngol. 1973;98(5):330-335. doi:10.1001/archotol.1973.00780020342013

Thirty-three cases of chemodectoma are presented, with patients staged in three groups: tympanic (1), tympanomastoid (2), and petrosal-extrapetrosal (3). Surgery is effective in group 1 cases.

Surgery and moderate-dose postoperative cobalt irradiation (3,500 to 4,000 rads in three weeks) are used for more advanced lesions with higher-dose irradiation (5,000 to 5,500 rads in five weeks) reserved for very extensive tumors. Overall control of tumor in these cases is 84% in follow-ups from 1 to 31 years.

Add or change institution